The 90/10 divide
BMJ 2002; 325 doi: https://doi.org/10.1136/sbmj.0208260 (Published 01 August 2002) Cite this as: BMJ 2002;325:0208260- Nathan Ford, Access to Medicines adviser1
- 1Médecins Sans Frontières, London EC1R 5DJ
Doctors confronting infectious disease in the less developed world are faced with impossible choices. Effective medicines exist to treat AIDS, but because patients in Africa cannot afford them doctors are left with little option but to tell them to go home and save up for their funeral.1
Patients with malaria are prescribed drugs that don't work because, although in some regions resistance to traditional medicines is over 90%,2 effective treatments are not available. The drug to treat sleeping sickness, melarsoprol, is an arsenic based medicine that kills one in 20 patients and doesn't work for one in three because of parasite resistance: the drug may kill the patient, but without treatment the patient will die anyway.3
Infectious diseases kill 14 million people each year, mostly in the less …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.